Oxford University is to begin a trail which will assess the Oxford.AstraZeneca vaccine efficacy in children aged 6 – 17.
Children who are as young as six will be part of the trail of 300 volunteers who will look at of the coronavirus vaccine will produce a strong immune response in children aged between 6 and 17.
the trail will start this month at Oxford University and at other locations in London, Southampton and Bristol.
The jab has already been one of three approved within the UK along with the Pfizer/BioNTech and Moderna.
Professor Andrew Pollard, chief investigator on the Oxford vaccine trial, said: “While most children are relatively unaffected by coronavirus and are unlikely to become unwell with the infection, it is important to establish the safety and immune response to the vaccine in children and young people as some children may benefit from.
“These new trials will extend our understanding of control of SARS-CoV2 to younger age groups.”
Up to 240 children will receive the vaccine and the others will get a control meningitis jab.